haemoglobin c protects clinical plasmodium falciparum malaria
haemoglobin c hbc beta 6glu -> lys common malarious areas west africa especially burkina faso conclusive evidence exists protective role severe malaria haemoglobin s hbs beta 6glu -> val heterozygosity whereas conflicting results hbc trait reported- epidemiological data exist possible role hbcc genotype vitro studies suggested hbcc erythrocytes fail support growth p falciparum hbc homozygotes high p falciparum parasitaemias observed show large case-control study performed burkina faso mossi subjects hbc associated % reduction risk clinical malaria hbac heterozygotes p % hbcc homozygotes p findings together limited pathology hbac hbcc compared severely disadvantaged hbss hbsc genotypes low beta s gene frequency geographic epicentre beta c1 support hypothesis long term absence malaria control hbc replace hbs central west africa
